Task: Answer the MCQ question.
Query: Which drug exhibits a 9.282% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a. COc1ccc(-c2noc(-c3ccccc3C(=O)Nc3cccnc3)n2)cc1OC
b. CSCCC(NC(=O)C1CC1)c1nc2ccccc2[nH]1
c. O=C(NC1CCCCCC1)C1Cc2ccccc2CN1C(=O)c1ccco1
d. Cc1cc(C)n(C2CCCCC2OC(=O)c2ccccc2)n1
Answer: b. CSCCC(NC(=O)C1CC1)c1nc2ccccc2[nH]1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CSCCC(NC(=O)C1CC1)c1nc2ccccc2[nH]1
CSCCC(NC(=O)C1CC1)c1nc2ccccc2[nH]1
N-[1-(1H-benzimidazol-2-yl)-3-methylsulfanylpropyl]cyclopropanecarboxamide